• Home
  • Publications
  • Clinical Trials
  • KLH in News
  • About KLH
  • Contact

KLH Site
  • Home
  • Publications
  • Clinical Trials
  • KLH in News
  • About KLH
  • Contact

Top
  • Home
  • Publications
  • Clinical Trials
  • KLH in News
  • About KLH
  • Contact
Search KLH Site
  • Clinical Trials RSS
  • Publications RSS
  • KLH in News RSS
Find Trials by Tags
Adjuvant GM-CSF (33) Adjuvant GPI-0100 (1) Adjuvant KLH (3) Adjuvant Oil / Surfactant (2) Adjuvant OPT-821/822 (7) Adjuvant QS-21 (16) BCI-ImmuneActivator (2) Bevacizumab (Avastin) (1) Dendritic Cell (25) Diagnostic Antigen (26) DTH (7) id-KLH (26) IL15 (1) Immucothel (3) Immune Response - Cellular (7) Immune Response - Humoral (12) KLH-Conjugate (70) KLH-EGFR (5) KLH-FITC (2) KLH-Ganglioside (11) KLH-Globo H (9) KLH-IFNa-Kinoid (1) KLH-Lewis-y (2) KLH-MUC (10) KLH-SLe (1) KLH-sTn (4) KLH-TF (5) KLH-Tn (5) KLH-TnFa-Kinoid (4) KLH-Tn-MUC (1) KLH-WT1 (3) Natalizumab (Tysabri) (1) Oral KLH (1) Rindopepimut (CDX-110) (6) Rituximab (Rituxan) (10) Temozolomide (Temodar) (1) Therapeutic Vaccine (96) Therapeutics - KLH Alone (3)
Terms and Privacy
  • Important Information
    • Read Terms of Use and Privacy Policy
Clinical Trial Categories
  • Age & Physical Activity (1)
  • Arthritis (2)
  • Asthma (1)
  • Cancer - Bladder (1)
  • Cancer - Brain & CNS (13)
  • Cancer - Breast (6)
  • Cancer - Colon (1)
  • Cancer - Digestive System (2)
  • Cancer - Female Reproductive (7)
  • Cancer - Gastric (1)
  • Cancer - Kidney (2)
  • Cancer - Leukemia (4)
  • Cancer - Liver (1)
  • Cancer - Lung (3)
  • Cancer - Lymphoma (27)
  • Cancer - Melanoma (13)
  • Cancer - Mesothelioma (2)
  • Cancer - Myeloma (9)
  • Cancer - Other (4)
  • Cancer - Pancreas (2)
  • Cancer - Peritoneal (5)
  • Cancer - Prostate (11)
  • Cancer - Sarcoma (1)
  • Cancer - Stomach (1)
  • Cancer - Testicular (1)
  • Cancer - Tissue (6)
  • Crohn's Disease (3)
  • Dermatitis (1)
  • Healthy (2)
  • Hepatitis C (2)
  • HIV (4)
  • Immune Disease - Autoimmune (8)
  • Immune Disease - Primary (2)
  • Immune Disease - Secondary (6)
  • Infectious Disease (2)
  • Inflammatory Disease (3)
  • Liver Disease (2)
  • Lupus Erythematosus (2)
  • Multiple Sclerosis (1)
  • Pediatric (2)
  • Transplant (1)
Thursday
Jan192012

NCT01516307

Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

Conditions: Metastatic Breast Cancer
Sponsors: Optimer Biotechnology, Inc.
Phase II

Date: DateJanuary 19, 2012
Categories CategoryCancer - Breast
Tags TagAdjuvant OPT-821/822, TagKLH-Conjugate, TagKLH-Globo H, TagTherapeutic Vaccine

PrintView Printer Friendly Version

EmailEmail Article to Friend

Copyright © 2012-2013 Stellar Biotechnologies, Inc. All rights reserved. www.stellarbiotech.com See Terms of Use & Privacy Policy.